The document provides information about COVID-19 vaccines and addresses common concerns among communities of color. It discusses how the vaccine was developed safely and effectively despite being developed quickly. It highlights that clinical trials included diverse participants and the vaccine was found to be over 95% effective and safe for all groups. The document encourages vaccination due to its benefits in protecting individuals and communities from COVID-19 and its serious long-term effects. It seeks to ease concerns by clarifying myths and providing trusted sources for additional information.
The document addresses common questions and concerns about the COVID-19 vaccine. It aims to provide factual information to alleviate fears and help promote vaccine acceptance. It explains that the vaccine was developed rapidly but still followed all safety protocols, that individuals who had COVID-19 may still benefit from the vaccine, and that reported side effects are typically mild and short-lived. The document emphasizes that the vaccine will be provided safely and at no cost to all.
The document addresses common questions and concerns about the COVID-19 vaccine. It aims to provide factual information to alleviate fears and promote vaccine acceptance. It explains that the vaccine was developed rapidly but still followed standard safety protocols, and that extensive testing was conducted on diverse populations. It also debunks myths about microchips, autism, infertility and notes that both approved vaccines have shown 95% effectiveness.
AAC Family Wellness (NY) - Vaccine Talk 2014stellablue
This document provides information about vaccines to help parents make informed choices. It discusses the history of vaccines and the rising vaccination schedule. Some key facts presented include that immune systems are not mature at birth and vaccines contain neurotoxins. Statistics are provided showing rising rates of chronic illnesses in children. The effectiveness and safety of certain vaccines is questioned. Natural immunity is compared to acquired immunity from vaccines. The document encourages examining risks and benefits of individual vaccines and knowing your legal rights to exemptions.
Millions of people in the United States have received COVID-19 vaccines under the most intense safety monitoring in US history. VITAS Healthcare offer an educational presentation for our partner organizations to use for their own in-house or staff training.
Vaccines have been very successful in eradicating devastating diseases, but this success means few people have seen the harms of these diseases firsthand. As a result, attention has shifted to perceived vaccine risks. Common myths include concerns about side effects, the vaccines being developed too quickly, and that the mRNA technology is too new. However, the document explains that potential side effects indicate the immune system is working as intended, no standards were broken during testing, and mRNA technology has been studied for a decade. Overall, the document aims to ease hesitancy by addressing myths and emphasizing vaccine safety and importance for community protection.
This document provides answers to common questions about the COVID-19 vaccines. It discusses that the first two vaccines approved are mRNA vaccines made by Pfizer and Moderna that do not contain the live virus. Both vaccines were found to be over 94% effective in clinical trials involving tens of thousands of participants. Common side effects after vaccination include fatigue, headache and pain at the injection site and are signs the immune system is working. While the vaccines are safe and effective, masks and other precautions will still be needed for some time.
This document provides information on immunizations for women in 2014. It discusses myths versus facts about vaccines, explains that vaccines do not cause autism or the diseases they protect against. It addresses safety and effectiveness of the influenza and Tdap vaccines during pregnancy. It recommends that all pregnant women receive the inactivated influenza vaccine each year from 27-36 weeks of pregnancy and the Tdap vaccine in each pregnancy. Minor and temporary side effects are common with vaccines while severe reactions are extremely rare.
The document discusses common myths about COVID-19 vaccines and provides facts to address hesitancy. It notes that side effects are usually mild and indicate the immune system is working. It also explains that vaccines were not developed too quickly and that all regulatory safety protocols were followed. The technology used has been studied for over a decade and mRNA vaccines do not alter DNA or cause infection. The information is evidence-based and transparently reported. The document aims to build trust in COVID-19 vaccines.
The document addresses common questions and concerns about the COVID-19 vaccine. It aims to provide factual information to alleviate fears and help promote vaccine acceptance. It explains that the vaccine was developed rapidly but still followed all safety protocols, that individuals who had COVID-19 may still benefit from the vaccine, and that reported side effects are typically mild and short-lived. The document emphasizes that the vaccine will be provided safely and at no cost to all.
The document addresses common questions and concerns about the COVID-19 vaccine. It aims to provide factual information to alleviate fears and promote vaccine acceptance. It explains that the vaccine was developed rapidly but still followed standard safety protocols, and that extensive testing was conducted on diverse populations. It also debunks myths about microchips, autism, infertility and notes that both approved vaccines have shown 95% effectiveness.
AAC Family Wellness (NY) - Vaccine Talk 2014stellablue
This document provides information about vaccines to help parents make informed choices. It discusses the history of vaccines and the rising vaccination schedule. Some key facts presented include that immune systems are not mature at birth and vaccines contain neurotoxins. Statistics are provided showing rising rates of chronic illnesses in children. The effectiveness and safety of certain vaccines is questioned. Natural immunity is compared to acquired immunity from vaccines. The document encourages examining risks and benefits of individual vaccines and knowing your legal rights to exemptions.
Millions of people in the United States have received COVID-19 vaccines under the most intense safety monitoring in US history. VITAS Healthcare offer an educational presentation for our partner organizations to use for their own in-house or staff training.
Vaccines have been very successful in eradicating devastating diseases, but this success means few people have seen the harms of these diseases firsthand. As a result, attention has shifted to perceived vaccine risks. Common myths include concerns about side effects, the vaccines being developed too quickly, and that the mRNA technology is too new. However, the document explains that potential side effects indicate the immune system is working as intended, no standards were broken during testing, and mRNA technology has been studied for a decade. Overall, the document aims to ease hesitancy by addressing myths and emphasizing vaccine safety and importance for community protection.
This document provides answers to common questions about the COVID-19 vaccines. It discusses that the first two vaccines approved are mRNA vaccines made by Pfizer and Moderna that do not contain the live virus. Both vaccines were found to be over 94% effective in clinical trials involving tens of thousands of participants. Common side effects after vaccination include fatigue, headache and pain at the injection site and are signs the immune system is working. While the vaccines are safe and effective, masks and other precautions will still be needed for some time.
This document provides information on immunizations for women in 2014. It discusses myths versus facts about vaccines, explains that vaccines do not cause autism or the diseases they protect against. It addresses safety and effectiveness of the influenza and Tdap vaccines during pregnancy. It recommends that all pregnant women receive the inactivated influenza vaccine each year from 27-36 weeks of pregnancy and the Tdap vaccine in each pregnancy. Minor and temporary side effects are common with vaccines while severe reactions are extremely rare.
The document discusses common myths about COVID-19 vaccines and provides facts to address hesitancy. It notes that side effects are usually mild and indicate the immune system is working. It also explains that vaccines were not developed too quickly and that all regulatory safety protocols were followed. The technology used has been studied for over a decade and mRNA vaccines do not alter DNA or cause infection. The information is evidence-based and transparently reported. The document aims to build trust in COVID-19 vaccines.
A teaching aid on addressing hesitancy to Covid-19 vaccination. WHO has identified vaccine hesitancy as a major threat to global health. Learn more about how to work with patients, the public and communities to improve confidence in Covid-19 vaccines.
The document addresses common questions and concerns about the COVID-19 vaccine. It explains that the vaccine was developed quickly but safely by conducting research concurrently instead of consecutively. It also clarifies that the vaccine will not make people sick with COVID-19 or contain tracking microchips. Side effects are explained to be mild like fever and pain at the injection site. The vaccine is deemed safe and effective for diverse populations.
1) The survey found that rare disease patients feel at high risk from COVID-19 due to underlying conditions, with many concerned about seeking healthcare due to exposure risk. Over half reported difficulty accessing medical care, rehabilitation, or critical services.
2) The results also showed that 40% had difficulty accessing medicines, with most barriers related to logistics or safety concerns rather than shortage. Three-fourths experienced increased anxiety or stress due to COVID-19.
3) Positive responses from healthcare providers included increased telehealth, home lab work, and continuing critical treatments. Pharmaceutical companies indicated drug supplies were secure and alternative arrangements were being made to ensure access.
This document addresses common myths about COVID-19 vaccines and provides facts to counter those myths. It discusses that side effects are minor and indicate the immune system is working, vaccines were not developed too quickly as governments prioritized development, and the mRNA technology used has been studied for over a decade. The document emphasizes that all regulatory safety and efficacy testing was completed before authorization to reassure about the vaccines.
This document discusses strategies for addressing vaccine hesitancy. It begins by defining vaccine hesitancy and outlining the key factors that influence it: confidence, complacency, and convenience. It then discusses how these factors have impacted vaccination rates, particularly among minority groups and those with lower socioeconomic status. The document reviews strategies that have been found to effectively build confidence in vaccines, such as strong recommendations from trusted healthcare providers, community partner promotion, and presenting information through stories and personal examples rather than statistics. It concludes by providing tips for discussing vaccines with hesitant patients, including acknowledging concerns, being knowledgeable, educating on vaccine testing, and emphasizing the recommendation.
The document discusses various topics related to vaccines including:
1) Vaccines provide active immunity against specific pathogens through the vaccination process.
2) While vaccines carry some risks, the medical, social and economic benefits of vaccines have led states to mandate childhood vaccination laws to prevent spread of preventable diseases.
3) There is a growing anti-vaccination movement in the US due to debunked claims about links between vaccines and autism, though scientific data shows that vaccines are generally more beneficial than harmful.
Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
This document discusses the trends in chickenpox (varicella) in the USA before and after the introduction of the varicella vaccine in 1995. Before 1995, around 4 million people in the USA would get chickenpox each year, resulting in over 10,000 hospitalizations and 100-150 deaths annually. The varicella vaccine was found to be safe and effective based on data from other countries where it was already in use. Studies also found the vaccine to be cost-effective. After the vaccine was recommended for children in 1995, rates of chickenpox declined significantly, reducing medical costs and lost work days associated with the disease.
Since coronavirus vaccines developed more quickly than other vaccines in the past, it has given rise to a few myths.
Let us review some common myths about the vaccine and clear up confusion with reliable facts from the management and healthcare practitioners at Urgent Care Hawaii.
The document discusses guidelines for diagnosing and treating high blood pressure from the National High Blood Pressure Education Program Coordinating Committee. It notes that systolic blood pressure is more important than diastolic pressure for those over 50 years old. It also discusses "prehypertension" between 120-139/80-89 mm Hg and treatment thresholds. The JNC 7 guidelines were issued in 1997 while the JNC 8 guidelines from 2013 include treatment algorithms and comparisons to JNC 7.
The document discusses guidelines for diagnosing and treating high blood pressure from the National High Blood Pressure Education Program Coordinating Committee. It notes that systolic blood pressure is more important than diastolic pressure for those over 50 years old. It also discusses "prehypertension" between 120-139/80-89 mm Hg and treatment thresholds. The JNC 7 guidelines were issued in 1997 while JNC 8 included treatment algorithms and differences from JNC 7.
Immunisatiion during pregnancy and post partum periodShivamurthy Hm
Immunization during pregnancy provides health benefits to both the pregnant woman and fetus by preventing vaccine-preventable diseases that can cause morbidity, mortality and complications affecting the pregnancy. While some inactivated vaccines are considered safe during pregnancy due to the lack of risk of transmitting the virus to the fetus, live attenuated vaccines are generally contraindicated due to theoretical risks. The benefits of vaccinating pregnant women usually outweigh potential risks when disease exposure is likely and infection could harm the mother or fetus.
Insights on Americans' perspectives on the COVID-19 vaccines, with effective language to build confidence in vaccination. Based on a poll conducted Dec. 21-22, 2020, by Frank Luntz and the de Beaumont Foundation in partnership with the American Public Health Association, the National Collaborative for Health Equity, and Resolve to Save Lives, an Initiative of Vital Strategies.
It seems that there are 3 methods to relaying information. The appeal to logic, where the speaker relies upon the hearers ability to think scientifically; the appeal to reason, wherein the speaker relies upon the hearers ability, if not to think scientifically, at least to understand a reasoned argument (A-B-C). Finally, one that is expressed farm or often today in our culture is the appeal to emotion. Often the appeal to emotion skirts facts and avoid reality, instead playing upon the vulnerability of uneducated people by creating a worst-case scenario. For my capstone project in my Public health Marketing course I decided to mix science and emotionality.
Jim McManus is the Director of Public Health for Hertfordshire. The document discusses strategies to address vaccine hesitancy for the COVID-19 vaccine. It defines vaccine hesitancy and outlines approaches for building confidence in the vaccine, including providing accurate information, acknowledging concerns, and promoting peer influence and role models. Barriers to vaccine uptake are addressed at both the organizational and individual level.
This document promotes awareness of vaccine safety issues and legal rights regarding vaccination. It advertises an upcoming radio show and e-book about vaccinations and rights in the US by Alan Phillips. It lists organizations providing vaccine information and discusses concerns about increased numbers of mandated vaccines, links between certain vaccines and health issues, lack of testing, and loss of choice in vaccination policies.
The document provides guidance for those working with refugee, immigrant, and migrant communities on communicating information about the COVID-19 vaccine. It discusses the development and testing of the three approved vaccines, their safety and efficacy. It also addresses concerns about access and distribution, noting the vaccines will be distributed in phases based on priority groups. Supporting vaccination in refugee, immigrant and migrant communities requires recognizing past trauma, providing translated materials, and addressing barriers to access like transportation or immigration concerns.
1. The document discusses North Carolina's COVID-19 response and vaccination plan. It provides data on current active clusters in K-12 schools and details the state's phased rollout of vaccines to priority groups like healthcare workers and long-term care residents and staff.
2. Information is given on the safety and efficacy of the Pfizer and Moderna vaccines. The plan is to distribute vaccines widely and equitably across the state through 2021 as supply increases.
3. North Carolinians are encouraged to continue practicing prevention measures like masks and distancing even after vaccination begins, as it will take time for most people to be vaccinated.
A dangerous trend is emerging in the USA where some parents are deliberately exposing their children to chickenpox (varicella) by mailing infected clothing or saliva in an attempt to contract the disease naturally. Before the varicella vaccine was introduced in 1995, chickenpox affected around 4 million Americans each year, resulting in over 10,000 hospitalizations and 100-150 deaths annually, mostly among healthy children. While the vaccine has dramatically reduced cases and complications in the USA, some parents now seek to infect their children at home rather than vaccinate, despite the health risks. Public health officials warn that these do-it-yourself infection attempts could spread the virus and endanger others.
1-A-MPP-ToxGurukul-Safety Evaluation of Vaccines.pptMukulPore3
The document summarizes a presentation on vaccine safety evaluation. It introduces vaccines, how they work, and the history of vaccine development. It discusses ideal vaccine characteristics and the vaccine development process, including clinical trial phases. It compares medicines and vaccines, noting both similarities like potential adverse effects, and key differences like vaccines being administered preventatively. The presentation covers ensuring safety in clinical trials and the importance of vaccine safety given vaccines are given to healthy individuals including children. It discusses categorizing vaccines and the types of nonclinical safety studies conducted.
The document discusses the composition and layers of the atmosphere. It notes that the atmosphere is composed of nitrogen, carbon dioxide, oxygen and other gases. Nitrogen is the most plentiful gas but plants cannot use it directly, instead relying on bacteria to fix nitrogen from the air. Carbon dioxide is used by plants for photosynthesis and contributes to the greenhouse effect. The layers of the atmosphere include the troposphere, stratosphere, mesosphere, and thermosphere. Weather occurs over short periods in a limited area while climate describes conditions over 30 years. Additional topics covered include temperature, insolation, air pressure, wind systems, rainfall, and the greenhouse effect.
This document appears to be a list of cartoon or planet titles along with their contents. There are multiple entries that repeat a title followed by unspecified content. The document concludes by thanking the reader for listening.
More Related Content
Similar to covid19-ca-alliance-vaccine-overview.pptx
A teaching aid on addressing hesitancy to Covid-19 vaccination. WHO has identified vaccine hesitancy as a major threat to global health. Learn more about how to work with patients, the public and communities to improve confidence in Covid-19 vaccines.
The document addresses common questions and concerns about the COVID-19 vaccine. It explains that the vaccine was developed quickly but safely by conducting research concurrently instead of consecutively. It also clarifies that the vaccine will not make people sick with COVID-19 or contain tracking microchips. Side effects are explained to be mild like fever and pain at the injection site. The vaccine is deemed safe and effective for diverse populations.
1) The survey found that rare disease patients feel at high risk from COVID-19 due to underlying conditions, with many concerned about seeking healthcare due to exposure risk. Over half reported difficulty accessing medical care, rehabilitation, or critical services.
2) The results also showed that 40% had difficulty accessing medicines, with most barriers related to logistics or safety concerns rather than shortage. Three-fourths experienced increased anxiety or stress due to COVID-19.
3) Positive responses from healthcare providers included increased telehealth, home lab work, and continuing critical treatments. Pharmaceutical companies indicated drug supplies were secure and alternative arrangements were being made to ensure access.
This document addresses common myths about COVID-19 vaccines and provides facts to counter those myths. It discusses that side effects are minor and indicate the immune system is working, vaccines were not developed too quickly as governments prioritized development, and the mRNA technology used has been studied for over a decade. The document emphasizes that all regulatory safety and efficacy testing was completed before authorization to reassure about the vaccines.
This document discusses strategies for addressing vaccine hesitancy. It begins by defining vaccine hesitancy and outlining the key factors that influence it: confidence, complacency, and convenience. It then discusses how these factors have impacted vaccination rates, particularly among minority groups and those with lower socioeconomic status. The document reviews strategies that have been found to effectively build confidence in vaccines, such as strong recommendations from trusted healthcare providers, community partner promotion, and presenting information through stories and personal examples rather than statistics. It concludes by providing tips for discussing vaccines with hesitant patients, including acknowledging concerns, being knowledgeable, educating on vaccine testing, and emphasizing the recommendation.
The document discusses various topics related to vaccines including:
1) Vaccines provide active immunity against specific pathogens through the vaccination process.
2) While vaccines carry some risks, the medical, social and economic benefits of vaccines have led states to mandate childhood vaccination laws to prevent spread of preventable diseases.
3) There is a growing anti-vaccination movement in the US due to debunked claims about links between vaccines and autism, though scientific data shows that vaccines are generally more beneficial than harmful.
Advisor Live: Zika virus disease – What you need to knowPremier Inc.
Presented as part of Premier’s AdvisorLive® series and co-sponsored by the Society for Healthcare Epidemiology of America (SHEA) and the Association for Professionals in Infection Control and Epidemiology (APIC)
This webinar covers:
* Updates and late breaking information on Zika virus outbreak, lab diagnosis and travel,
* Issues for reproductive age and pregnant women, including evaluation, management, counseling, and congenital findings, and
* Implications and risks for healthcare personnel.
EXPERT PRESENTERS:
* Joanne Cono, MD, ScM, Director, Office of Science Quality, Office of the Director, Centers for Disease Control and Prevention (CDC)
* Jeanne S. Sheffield, MD, Director of Maternal-Fetal Medicine and Professor, Johns Hopkins Medicine
* Moderator: Gina Pugliese, RN, MS, Vice President, Premier Safety Institute
This document discusses the trends in chickenpox (varicella) in the USA before and after the introduction of the varicella vaccine in 1995. Before 1995, around 4 million people in the USA would get chickenpox each year, resulting in over 10,000 hospitalizations and 100-150 deaths annually. The varicella vaccine was found to be safe and effective based on data from other countries where it was already in use. Studies also found the vaccine to be cost-effective. After the vaccine was recommended for children in 1995, rates of chickenpox declined significantly, reducing medical costs and lost work days associated with the disease.
Since coronavirus vaccines developed more quickly than other vaccines in the past, it has given rise to a few myths.
Let us review some common myths about the vaccine and clear up confusion with reliable facts from the management and healthcare practitioners at Urgent Care Hawaii.
The document discusses guidelines for diagnosing and treating high blood pressure from the National High Blood Pressure Education Program Coordinating Committee. It notes that systolic blood pressure is more important than diastolic pressure for those over 50 years old. It also discusses "prehypertension" between 120-139/80-89 mm Hg and treatment thresholds. The JNC 7 guidelines were issued in 1997 while the JNC 8 guidelines from 2013 include treatment algorithms and comparisons to JNC 7.
The document discusses guidelines for diagnosing and treating high blood pressure from the National High Blood Pressure Education Program Coordinating Committee. It notes that systolic blood pressure is more important than diastolic pressure for those over 50 years old. It also discusses "prehypertension" between 120-139/80-89 mm Hg and treatment thresholds. The JNC 7 guidelines were issued in 1997 while JNC 8 included treatment algorithms and differences from JNC 7.
Immunisatiion during pregnancy and post partum periodShivamurthy Hm
Immunization during pregnancy provides health benefits to both the pregnant woman and fetus by preventing vaccine-preventable diseases that can cause morbidity, mortality and complications affecting the pregnancy. While some inactivated vaccines are considered safe during pregnancy due to the lack of risk of transmitting the virus to the fetus, live attenuated vaccines are generally contraindicated due to theoretical risks. The benefits of vaccinating pregnant women usually outweigh potential risks when disease exposure is likely and infection could harm the mother or fetus.
Insights on Americans' perspectives on the COVID-19 vaccines, with effective language to build confidence in vaccination. Based on a poll conducted Dec. 21-22, 2020, by Frank Luntz and the de Beaumont Foundation in partnership with the American Public Health Association, the National Collaborative for Health Equity, and Resolve to Save Lives, an Initiative of Vital Strategies.
It seems that there are 3 methods to relaying information. The appeal to logic, where the speaker relies upon the hearers ability to think scientifically; the appeal to reason, wherein the speaker relies upon the hearers ability, if not to think scientifically, at least to understand a reasoned argument (A-B-C). Finally, one that is expressed farm or often today in our culture is the appeal to emotion. Often the appeal to emotion skirts facts and avoid reality, instead playing upon the vulnerability of uneducated people by creating a worst-case scenario. For my capstone project in my Public health Marketing course I decided to mix science and emotionality.
Jim McManus is the Director of Public Health for Hertfordshire. The document discusses strategies to address vaccine hesitancy for the COVID-19 vaccine. It defines vaccine hesitancy and outlines approaches for building confidence in the vaccine, including providing accurate information, acknowledging concerns, and promoting peer influence and role models. Barriers to vaccine uptake are addressed at both the organizational and individual level.
This document promotes awareness of vaccine safety issues and legal rights regarding vaccination. It advertises an upcoming radio show and e-book about vaccinations and rights in the US by Alan Phillips. It lists organizations providing vaccine information and discusses concerns about increased numbers of mandated vaccines, links between certain vaccines and health issues, lack of testing, and loss of choice in vaccination policies.
The document provides guidance for those working with refugee, immigrant, and migrant communities on communicating information about the COVID-19 vaccine. It discusses the development and testing of the three approved vaccines, their safety and efficacy. It also addresses concerns about access and distribution, noting the vaccines will be distributed in phases based on priority groups. Supporting vaccination in refugee, immigrant and migrant communities requires recognizing past trauma, providing translated materials, and addressing barriers to access like transportation or immigration concerns.
1. The document discusses North Carolina's COVID-19 response and vaccination plan. It provides data on current active clusters in K-12 schools and details the state's phased rollout of vaccines to priority groups like healthcare workers and long-term care residents and staff.
2. Information is given on the safety and efficacy of the Pfizer and Moderna vaccines. The plan is to distribute vaccines widely and equitably across the state through 2021 as supply increases.
3. North Carolinians are encouraged to continue practicing prevention measures like masks and distancing even after vaccination begins, as it will take time for most people to be vaccinated.
A dangerous trend is emerging in the USA where some parents are deliberately exposing their children to chickenpox (varicella) by mailing infected clothing or saliva in an attempt to contract the disease naturally. Before the varicella vaccine was introduced in 1995, chickenpox affected around 4 million Americans each year, resulting in over 10,000 hospitalizations and 100-150 deaths annually, mostly among healthy children. While the vaccine has dramatically reduced cases and complications in the USA, some parents now seek to infect their children at home rather than vaccinate, despite the health risks. Public health officials warn that these do-it-yourself infection attempts could spread the virus and endanger others.
1-A-MPP-ToxGurukul-Safety Evaluation of Vaccines.pptMukulPore3
The document summarizes a presentation on vaccine safety evaluation. It introduces vaccines, how they work, and the history of vaccine development. It discusses ideal vaccine characteristics and the vaccine development process, including clinical trial phases. It compares medicines and vaccines, noting both similarities like potential adverse effects, and key differences like vaccines being administered preventatively. The presentation covers ensuring safety in clinical trials and the importance of vaccine safety given vaccines are given to healthy individuals including children. It discusses categorizing vaccines and the types of nonclinical safety studies conducted.
Similar to covid19-ca-alliance-vaccine-overview.pptx (20)
The document discusses the composition and layers of the atmosphere. It notes that the atmosphere is composed of nitrogen, carbon dioxide, oxygen and other gases. Nitrogen is the most plentiful gas but plants cannot use it directly, instead relying on bacteria to fix nitrogen from the air. Carbon dioxide is used by plants for photosynthesis and contributes to the greenhouse effect. The layers of the atmosphere include the troposphere, stratosphere, mesosphere, and thermosphere. Weather occurs over short periods in a limited area while climate describes conditions over 30 years. Additional topics covered include temperature, insolation, air pressure, wind systems, rainfall, and the greenhouse effect.
This document appears to be a list of cartoon or planet titles along with their contents. There are multiple entries that repeat a title followed by unspecified content. The document concludes by thanking the reader for listening.
The solar system consists of the sun and nine planets along with their satellites and other celestial bodies like asteroids and meteoroids. Celestial bodies are objects that shine in the night sky, including the sun, moon, and stars. Stars are big, hot bodies made of gas that produce their own heat and light, with the sun being the closest star to Earth, though stars appear small because of their vast distances from us.
The document discusses what ancient Indian texts and burials can tell us about history. It provides details on the four Vedas, which are among India's greatest and oldest texts containing hymns, mantras and rituals. It describes the Rigveda as the oldest, composed around 3500 years ago addressing gods like Agni and soma. It also outlines burial practices like megaliths and sites in India from around 3000 years ago where artifacts and skeletons were found buried with pots, tools and ornaments indicating differences in status.
New kingdom and empires
1. If acting as Samudragupta, Arvind would have to march in splendid robes, wield a silver-paper wrapped sword, sit on the throne playing veena and reciting poetry, and fight several battles.
2. During this time period, some important administrative posts became hereditary and one person sometimes held multiple offices, like the poet Harishena.
3. Local administration also likely involved important figures like merchants, craftsmen, and scribes.
INDIA CLIMATE VEGETATION AND WILDLIFE.pptxravi429324
India has four major seasons: the cold winter season from December to February where temperatures are quite low in northern India; the hot summer season from March to May where temperatures become very high and hot, dry winds called "loo" blow; the southwest monsoon season from June to September which brings rainfall as moist winds from the Arabian Sea and Bay of Bengal strike mountain barriers; and the retreating monsoon season of October and November where winds move back to the Bay of Bengal and southern parts of India receive rainfall.
India is located in South Asia. It is the 7th largest country by area, covering an area of about 3.28 million square kilometers. India shares land borders with Pakistan, Afghanistan, China, Nepal, Bhutan, Bangladesh and Myanmar. The Himalayas lie to the north, while the Thar Desert lies to the west. India has a highly diverse geography, with mountains, deserts, rainforests, and plains. It is administratively divided into 28 states and 8 union territories for governance. A large population lives in the highly fertile northern plains watered by major rivers like the Ganges and Indus.
Human environment interaction, Tropical regionravi429324
The Amazon basin stretches across South America near the equator between 10°N and 10°S. It has a hot and wet climate all year with heavy rainfall. Thick rainforests grow in the basin, and the dense canopy prevents sunlight from reaching the ground, supporting shade-tolerant vegetation. The basin is home to a vast diversity of both plant and animal life. The people of the Amazon mainly practice slash-and-burn agriculture or grow crops like manioc, their staple food. Their way of life is gradually changing with new infrastructure making more of the forest accessible.
The document discusses the rise and expansion of the Gupta Empire in ancient India between the 4th and 6th centuries CE. It describes how Samudragupta, a ruler of the Gupta Dynasty, conquered territories across northern and central India and forced neighboring kingdoms to submit to his authority through military might. Samudragupta categorized different types of rulers based on their relationship to his empire and established control over a vast region. The document also briefly mentions Chandragupta II and the historical text Harshacharita, which provides details about the rule of King Harshavardhana.
Regional cultures are formed through the intermingling of local traditions with influences from other areas. Some key aspects that help associate people into regional cultures include shared language, food, cultural practices, clothing, and dance and music traditions. Regional identities emerge from the blending of local customs with ideas transmitted throughout the subcontinent.
The tropical region lies close to the equator between 10 degrees north and south. Both day and night are hot and humid, though nights are cooler. The Amazon river basin drains parts of several South American countries. Vegetation is mostly shade tolerant. Birds like hummingbirds live in the tropical region. Snakes such as the boa constrictor and largest snakes like anacondas and reticulated pythons are found there. Crops grown include coffee, maize, cocoa, tapioca, pineapple and sweet potato, while manioc is a staple food. Men hunt and fish along rivers and women tend crops.
This presentation from the Georgia Department of Public Health covers childhood immunization updates. It discusses the importance of vaccines in preventing diseases and herd immunity thresholds. Recent immunization schedule changes and ACIP recommendations for several vaccines including DTaP, hepatitis A, hepatitis B, Hib, HPV, influenza, measles/mumps/rubella, and varicella are summarized. Product updates and best practice guidelines for vaccine administration and storage are also reviewed.
The document discusses the benefits of immunization through vaccination. It states that vaccines save up to 3 million lives annually and protect against 26 infectious diseases. While immunization has reduced diseases like polio and eradicated smallpox, declining vaccine coverage puts progress at risk and has led to outbreaks of measles in Europe. The document outlines how vaccines work, the importance of community immunity through sufficient vaccination coverage, vaccine safety testing, common myths about vaccines, and strategies to communicate with patients about vaccines.
This document summarizes key education initiatives in India. It discusses 3 main projects: 1) an online teacher training program that has reached over 40,000 secondary school teachers, 2) a career guidance program that has reached over 100 million students across 5 states, and 3) a life skills curriculum that reaches 3.4 million students annually. It emphasizes the importance of vocational education according to the National Education Policy of 2020 and outlines strategies to improve perceptions of vocational education. These include developing student interests and aptitudes, exploring opportunities, and facilitating informed choices to lead to gainful employment.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
2. COVID Impact on Communities of Color
https://covid19.ca.gov/equity/
3.
4. Common Concerns
• Mistrust based on historic and contemporary mistreatment of Black,
Latino, Asian, Pacific Islander, American Indian communities
• Vaccine developed under political pressure
• Vaccine is new and developed quickly
• Lack of universal trusted source of information, different sources of
different information, inconsistent information
Concerns of vaccine hesitancy are valid, respectable, and
should be answered by a qualified physician or agency
5. Benefits of Getting Vaccine
• Vaccination protects you, your family, and your community
from any symptomatic COVID-19
• Pfizer and Moderna vaccines are both 95% effective in preventing
ANY symptoms of COVID-19
• Annual flu vaccines are usually only 40-60% effective yet they have
reduced the flu, severe cases of the flu, and death
• Reduces the chance of hospitalization and death from
COVID-19
• Being unvaccinated may increase your risk of getting
COVID-19 and serious long-term complications
6. Vaccine Development
Was the vaccine rushed?
• Scientists developed vaccine, not the government
• Vaccine was developed and tested quickly, but safely. There
were no “skipping” of steps.
• Lots of government and private funding + more cooperation
across scientific labs nationally and internationally = multiple
expensive clinical trials at the same time
• Vaccine technology has been studied for many years
• Think of it like when we moved from rotary phones to cellular phones
7. What is in the vaccine?
How does the vaccine work?
• The vaccine includes protein (mRNA), fats (called lipids), salt and
sugar (preservatives)
• The vaccine has no animal products (halal) or thimerosal. No fetal
tissue was used to make the vaccine. These vaccines do not contain
any parts of the coronavirus and cannot cause COVID-19.
• Cannot alter your DNA in any way
• The mRNA is a messenger that teaches your body how to recognize
and respond to COVID-19. Then it disappears.
• Like Snapchat
• mRNA technology has been studied for over 30 years
8. First camera phone
Facebook launches
First iPhone
Twitter launches
1990s
Dr. Katalin Karikó begain
studying mRNA technology
for humans at Temple, then
UPenn
2000
Dr. Barney Graham, head of
Vanderbilt AIDS Vaccine
Evalution Unit, recruited as
one of founders of NIH
Vaccine Research Center
2002
SARS-CoV-1
2005
Dr. Karikó and Dr. Drew
Weissman created
successful synthetic mRNA
delivery system
2012
MERS
2013
Dr. Graham and Dr. Jason
McLellan solved way to
modify RSV virus prefusion
spike protein to allow for
successful structure-based
vaccine
Dr. Karikó joins BioNTech to
oversee mRNA research
2014
Dr. Kizzmekia Corbett
appointed to NIH Vaccine
Research Center after years
of working on viruses and
vaccines
2017
Dr. McLellan (UT Austin)
and Dr. Andrew Ward
(Scripps Research) figured
out coronavirus prefusion
spike structure
Dr. Graham partners with
Moderna for mRNA MERS
vaccine
2020
SARS-CoV-2
https://cen.acs.org/pharmaceuticals/vaccines/tiny-tweak-behind-COVID-19/98/i38
Dr. Graham and Dr.
Corbett get genetic
code for virus to create
structure-based
SARS-CoV-2 vaccine
with Moderna
@ScrippsSHARCs
Timeline of mRNA technology and key figures in vaccine development
9. Were people like me part of
the clinical trials?
Over 70,000 people participated in Pfizer and Moderna trials and
were equally safe for all:
• Adults, all ages (65+, over 85% effective)
• Race/ethnicities (Black, Latino, other communities of color,
over 95% effective)
• Chronic conditions (about 90% effective)
The vaccine is safe and can prolong your immunity if you have
already had COVID-19.
10. Race/Ethnicity in COVID-19
Clinical Trials
Moderna
Moderna and Pfizer clinical trials included a broad range of
diverse participants
Percent Racial/Ethnic group
20.5% Hispanic/Latino
9.7% Black
4.7% Asian
2.1% Multiracial
0.8% American Indian
0.2% Pacific Island
Pfizer
Percent Racial/Ethnic group
26.2% Hispanic/Latino
9.8% Black
4.4% Asian
2.5% Multiracial
0.6% American Indian
0.2% Pacific Island
12. Side Effects
• Most side effects are mild, may occur over a few days, and can
be stronger after your second dose.
• Common side effects include pain or muscle ache, fatigue,
headache, nausea, chills, and fever.
• After vaccination, medical personnel will monitor you for 15 minutes to
ensure you get any necessary treatment if you have a reaction
(medical treatment & personnel on site)
13. Side Effects
• Serious side effects are rare. The vaccine is safe for you if you
have seasonal, pet, or food allergies.
• If you have a history of anaphylaxis (severe allergic reactions),
previous vaccine reactions, are allergic to polysorbate or ethylene
glycol, talk to your doctor.
• There is no evidence the vaccine affects fertility.
• Talk to your doctor if you: are immunocompromised or are
taking medication that affects your immune system, have been
unable to receive vaccinations in the past because of a blood
thinner or a bleeding disorder, have a fever, are pregnant, or
plan to become pregnant.
15. Which vaccine is better?
Can I choose?
Both Pfizer and Moderna
vaccines are about 95%
effective.
At this point, due to limited
supply, you cannot choose.
• Pfizer and Moderna each
have two doses, spaced
apart 3-4 weeks.
• Your first shot needs to be
the same as your second
shot.
• Pfizer approved for people
over 16; Moderna is
approved for people over 18.
16. Do I need both shots?
Yes. The current vaccines have two doses, spaced apart 21 or 28 days. It is
possible to get infected with COVID-19 before your second dose because
you are not yet fully protected.
Will I have to take the vaccine again?
• Scientists are not sure how long the vaccines will protect people. They are
continuing to monitor the data in order to make recommendations. It’s
possible there will be a need for booster shots in the future.
• What is known is that you need both doses (shots) for the Pfizer and
Moderna vaccines to be effective.
17. Will the vaccines protect against new
mutations?
So far, the current vaccines appear to still protect you against the
new mutation (it doesn’t appear to be a significant change).
How much will it cost?
The vaccines have been covered by taxpayer dollars, so they will
be free to everyone.
18. Why are some communities, such as
Black, Latinx, American Indian, Pacific
Islander, or Asian American, being
encouraged to get the vaccine?
• Some communities (such as Black/African American, Latino/x,
American Indian, Pacific Islander, Indigenous, and Asian
populations) may be offered the vaccines earlier than others
because their infection, hospitalization, and death rates have been
disproportionately high.
• This is related to higher rates of exposure (essential work,
multigenerational households, etc). For this same reason, prevention
is crucial.
19. What is herd immunity?
How does it work?
• We reached herd immunity for
measles, mumps, polio, and
chickenpox in the U.S. through
vaccines.
• Scientists expect herd immunity
with 80-90% of people
vaccinated.
• However, herd immunity applies
to the community around you.
That’s why you’ll see outbreaks
(e.g., measles) in communities
with low vaccine uptake.
• Herd immunity without a vaccine
will result in catastrophic numbers
of deaths.
https://www.jhsph.edu/covid-19/articles/achieving-herd-immunity-with-covid19.html
https://www.ucdavis.edu/covid-19/what-to-know-about-herd-immunity/
20. Should I get the vaccine even if I
already had COVID-19?
Yes. Protection from the vaccine is safe and can prolong your
immunity. You can wait up to 90 days after infection for
vaccination but can receive it as soon as local regulations allow.
Do I still need to wear a mask after
getting the vaccine?
Yes. The vaccines protect YOU from getting sick from COVID-19, but it is
unclear whether you may still get mild or symptom-free cases, then transmit
COVID-19 to others. Continue to follow public health guidelines, such as
wearing a mask, social distancing, and avoiding indoor crowds.
22. Weighing the Risks:
Infection vs. Vaccination
Every million cases of
COVID-19 infection
~15,000 deaths
~70,000 hospitalizations
Every million COVID-19
vaccinations
~2-3 serious reactions
~1-2 hospitalizations
1-2 deaths under investigation
Moderna and Pfizer vaccine each reported 10 serious allergic reactions out of 4 million doses (as of 1/23/21)
24. Key Takeaways
• Lot of misinformation in social media and word-of-mouth
• Black, Latino, Asian, Pacific Islander, American Indian
communities are contracting disease and dying at higher rates
• “Side effects” of contracting COVID-19 disease is far worse
than side effects of getting the vaccine
• Why consider taking vaccine if you have mistrust? Because we
want everyone to stay alive today to help fight mistrust
tomorrow.
25. Resources
• STOP COVID-19 CA website: https://www.stopcovid-19ca.org/
• COVID-19 Vaccine FAQ in community-friendly language:
English and Spanish
• NIH CEAL (Community Engagement Alliance) Against COVID-19 Disparities
website: https://covid19community.nih.gov/
• CDC COVID-19 Vaccine Communications Toolkit for CBO:
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/toolkits/community-
organization.html
• CDC COVID-19 website: https://www.cdc.gov/coronavirus/2019-ncov/index.html
• ASTHO (Association of State and Territorial Health Officials) COVID-19 website:
https://astho.org/COVID-19/
27. Jan 25, 2021
State Population 39M
COVID Cases 3.136M
COVID Deaths 37,543
28. What safeguards are in place now to
protect people of color?
The Belmont Report was created in response to the Tuskegee Syphilis Study – it
applies to all people but was done in response to mistreatment to people of color
• 3 principles for ethical conduct of research involving human participants:
1) Respect for persons; 2) Beneficence; and 3) Justice.
• Institutional Review Board (IRB), must approve every US clinical trial.
• The IRB is made up of doctors, scientists, and lay people, dedicated to making sure
that the study participants are not exposed to unnecessary risks.
• Informed consent process also helps protect participants.
• Before joining a clinical trial, study participants will be told what to expect and all the
things that might happen.
• Large clinical trials have a Data Safety Monitoring Board
• New medications and vaccines also go through FDA Review